
The Global Fund to Fight AIDS, Tuberculosis, and Malaria has confirmed that Congressman Jim Kolbe of Arizona is one of five candidates under consideration to become its new executive director.
Kolbe is set to retire at the end of the year after 22 years in Congress. As chairman of the House appropriations subcommittee on foreign operations, export financing, and related programs, he helps oversee more than half the United States' contribution to the fund, according to fund spokesman Seth Amgott. The Geneva-based fund receives about one third of its money from the United States.
Spokespeople for both the fund and the congressman said it is not a conflict of interest for him to apply for the job while continuing to serve on the committee. Korenna Cline of Kolbe's office said the committee took up its last foreign operations bill in the spring. On May 25 the committee approved a bill allocating $3.4 billion for the global fight against AIDS, TB, and malaria, including a contribution of $445 million for the Global Fund. In July the fund launched its search for a new executive director. House records show Kolbe accepted $7,226 from the fund to travel to Geneva September 17–19 for a "position interview."
Gary Ruskin of the watchdog group Congressional Accountability Project said he too sees no conflict of interest: "We wish more members of Congress would follow his example instead of becoming hired guns—help people who need help." CAP, however, has said House ethics rules should require more disclosures when members apply for other jobs. Ruskin said Kolbe should say whether he has done anything for the fund since becoming a job candidate. The House Ethics Committee, Cline said, had approved Kolbe's trip to Geneva.
The final decision will be made when the Global Fund's full board meets at the end of the month. The position pays about $173,000 plus a pension. (AP)
These comments are reproduced as written by visitors to this Web site. They have not been edited for content, grammar, or spelling. The viewpoints appearing here are those of the writer, and do not necessarily reflect the opinion or views of advocate.com, The Advocate, or its affiliates.
Be the first to comment on this story.
If you would like to submit a comment for posting, please fill out the form above.
All comments submitted via this form are subject to posting or publication. (To send a private letter to an Advocate editor or writer, please use the e-mail button at the top of the page, or use snail mail.) If you would like your comment considered for publication in The Advocate magazine, please include your full name, your city of residence, and a phone number where you can be reached during business hours so that we can confirm your identity. Your e-mail address and telephone number are strictly confidential and will not be shared or used for any purpose other than to contact you about your comment.
See the Contact page for sending comments for reasons other than responding to Advocate editorial and news stories.
Please note that comments sent by fax or snail mail are unlikely to be posted, although they will be considered for publication along with all letters received via e-mail or via this Web page. Comments that chiefly concern Advocate.com content will be considered for posting only on the Web site. The Advocate reserves the right to edit submitted comments for grammar, spelling, obscenities, or libel; we will, however, do our best to preserve the original comment's style and intent. Comments considered for publication in The Advocate magazine may also be edited for length.